{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:02:34Z","timestamp":1791054154433,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04559-0","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:16:31Z","timestamp":1759914991000},"page":"3715-3725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between atorvastatin and sarcopenia: a study based on NHANES and FAERS databases"],"prefix":"10.1007","volume":"399","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Pan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi Hong","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"4559_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-0716-0471-7_2","volume":"2138","author":"B Abiri","year":"2020","unstructured":"Abiri B, Vafa M (2020) Vitamin D and muscle sarcopenia in aging. Methods Mol Biol 2138:29\u201347. https:\/\/doi.org\/10.1007\/978-1-0716-0471-7_2","journal-title":"Methods Mol Biol"},{"issue":"3","key":"4559_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.31557\/apjcp.2022.23.3.867","volume":"23","author":"R Abolghasemi","year":"2022","unstructured":"Abolghasemi R, Ebrahimi-Barough S, Bahrami N, Ai J (2022) Atorvastatin inhibits viability and migration of MCF7 breast cancer cells. Asian Pac J Cancer Prev 23(3):867\u2013875. https:\/\/doi.org\/10.31557\/apjcp.2022.23.3.867","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"4559_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nbt.2113","volume":"30","author":"R B\u00f6hm","year":"2012","unstructured":"B\u00f6hm R, H\u00f6cker J, Cascorbi I, Herdegen T (2012) OpenVigil\u2013free eyeballs on AERS pharmacovigilance data. Nat Biotechnol 30(2):137\u2013138. https:\/\/doi.org\/10.1038\/nbt.2113","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4559_CR4","first-page":"1219","volume":"26","author":"S Cai","year":"2021","unstructured":"Cai S, Gao Z (2021) Atorvastatin inhibits proliferation and promotes apoptosis of colon cancer cells via COX-2\/PGE2\/\u03b2-catenin pathway. J Buon 26(4):1219\u20131225","journal-title":"J Buon"},{"issue":"10","key":"4559_CR5","doi-asserted-by":"publisher","first-page":"1720.e11","DOI":"10.1016\/j.jamda.2022.06.016","volume":"23","author":"N Campo-Rivera","year":"2022","unstructured":"Campo-Rivera N, Ocampo-Chaparro JM, Carvajal-Ortiz R, Reyes-Ortiz CA (2022) Sarcopenic dysphagia is associated with mortality in institutionalized older adults. J Am Med Dir Assoc 23(10):1720.e11-1720.e17. https:\/\/doi.org\/10.1016\/j.jamda.2022.06.016","journal-title":"J Am Med Dir Assoc"},{"issue":"38","key":"4559_CR6","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.2174\/1381612825666190117114305","volume":"24","author":"M Doumas","year":"2018","unstructured":"Doumas M, Imprialos K, Dimakopoulou A, Stavropoulos K, Binas A, Athyros VG (2018) The role of statins in the management of nonalcoholic fatty liver disease. Curr Pharm des 24(38):4587\u20134592. https:\/\/doi.org\/10.2174\/1381612825666190117114305","journal-title":"Curr Pharm des"},{"issue":"4","key":"4559_CR7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2741\/4338","volume":"20","author":"Y Duan","year":"2015","unstructured":"Duan Y, Li F, Liu H et al (2015) Nutritional and regulatory roles of leucine in muscle growth and fat reduction. Front Biosci (Landmark Ed) 20(4):796\u2013813. https:\/\/doi.org\/10.2741\/4338","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"4559_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.22092\/ari.2021.356683.1895","volume":"77","author":"KM Hassani","year":"2022","unstructured":"Hassani KM (2022) Investigation of the effect of atorvastatin on skeletal muscles in male rats and the involved mechanisms. Arch Razi Inst 77(1):285\u2013291. https:\/\/doi.org\/10.22092\/ari.2021.356683.1895","journal-title":"Arch Razi Inst"},{"issue":"5","key":"4559_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/bcpt.12808","volume":"121","author":"H Kim","year":"2017","unstructured":"Kim H, Kim N, Lee DH, Kim HS (2017) Analysis of national pharmacovigilance data associated with statin use in Korea. Basic Clin Pharmacol Toxicol 121(5):409\u2013413. https:\/\/doi.org\/10.1111\/bcpt.12808","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"4559_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bbrc.2018.11.166","volume":"508","author":"WH Kim","year":"2019","unstructured":"Kim WH, Lee CH, Han JH et al (2019) C\/EBP homologous protein deficiency inhibits statin-induced myotoxicity. Biochem Biophys Res Commun 508(3):857\u2013863. https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.166","journal-title":"Biochem Biophys Res Commun"},{"key":"4559_CR11","doi-asserted-by":"publisher","unstructured":"Leung YH, Turgeon J, Michaud V. Study of statin- and loratadine-induced muscle pain mechanisms using human skeletal muscle cells. Pharm. 2017;9(4). https:\/\/doi.org\/10.3390\/pharmaceutics9040042","DOI":"10.3390\/pharmaceutics9040042"},{"issue":"8","key":"4559_CR12","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1111\/bcp.15757","volume":"89","author":"JL Montastruc","year":"2023","unstructured":"Montastruc JL (2023) Rhabdomyolysis and statins: a pharmacovigilance comparative study between statins. Br J Clin Pharmacol 89(8):2636\u20132638. https:\/\/doi.org\/10.1111\/bcp.15757","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"4559_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","volume":"75","author":"FS Nahm","year":"2022","unstructured":"Nahm FS (2022) Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol 75(1):25\u201336. https:\/\/doi.org\/10.4097\/kja.21209","journal-title":"Korean J Anesthesiol"},{"key":"4559_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.etap.2017.03.021","volume":"52","author":"R Pasha","year":"2017","unstructured":"Pasha R, Moon TW (2017) Coenzyme Q10 protects against statin-induced myotoxicity in zebrafish larvae (Danio rerio). Environ Toxicol Pharmacol 52:150\u2013160. https:\/\/doi.org\/10.1016\/j.etap.2017.03.021","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"4559_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","volume":"13","author":"F Petermann-Rocha","year":"2022","unstructured":"Petermann-Rocha F, Balntzi V, Gray SR et al (2022) Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 13(1):86\u201399. https:\/\/doi.org\/10.1002\/jcsm.12783","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"7","key":"4559_CR16","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda T, Tamon A, Kadoyama K, Okuno Y (2013) Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci 10(7):796\u2013803. https:\/\/doi.org\/10.7150\/ijms.6048","journal-title":"Int J Med Sci"},{"issue":"1","key":"4559_CR17","doi-asserted-by":"publisher","first-page":"e001447","DOI":"10.1136\/bmjph-2024-001447","volume":"3","author":"Y She","year":"2025","unstructured":"She Y, Zhu L, Guo X et al (2025) Association between the composite dietary antioxidant index and sarcopenia risk in American adults: a cross-sectional NHANES study. BMJ Public Health 3(1):e001447. https:\/\/doi.org\/10.1136\/bmjph-2024-001447","journal-title":"BMJ Public Health"},{"issue":"3","key":"4559_CR18","doi-asserted-by":"publisher","first-page":"e23463","DOI":"10.7759\/cureus.23463","volume":"14","author":"I Suliman","year":"2022","unstructured":"Suliman I, Batarfi A, Almohammadi H, Aljeraisi H, Alnaserallah H, Alghamdi A (2022) Prevalence of self-reported muscle pain among statin users From National Guard Hospital, Riyadh. Cureus 14(3):e23463. https:\/\/doi.org\/10.7759\/cureus.23463","journal-title":"Cureus"},{"issue":"4","key":"4559_CR19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/s1734-1140(11)70601-6","volume":"63","author":"M Tomaszewski","year":"2011","unstructured":"Tomaszewski M, St\u0119pie\u0144 KM, Tomaszewska J, Czuczwar SJ (2011) Statin-induced myopathies. Pharmacol Rep 63(4):859\u2013866. https:\/\/doi.org\/10.1016\/s1734-1140(11)70601-6","journal-title":"Pharmacol Rep"},{"issue":"11","key":"4559_CR20","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jsps.2020.08.025","volume":"28","author":"AS Tulbah","year":"2020","unstructured":"Tulbah AS (2020) The potential of atorvastatin for chronic lung diseases therapy. Saudi Pharm J 28(11):1353\u20131363. https:\/\/doi.org\/10.1016\/j.jsps.2020.08.025","journal-title":"Saudi Pharm J"},{"issue":"Suppl 3","key":"4559_CR21","doi-asserted-by":"publisher","first-page":"S407","DOI":"10.5281\/zenodo.8319748","volume":"61","author":"VE Villegas-Quintero","year":"2023","unstructured":"Villegas-Quintero VE, Rivas-Ru\u00edz R, Garc\u00eda-Rivero AA, Rivera-Lara P, Gonz\u00e1lez-Tovar NB (2023) Efficacy and safety of atorvastatin in major cardiovascular events: Meta-analysis. Rev Med Inst Mex Seguro Soc. 61(Suppl 3):S407-s415. https:\/\/doi.org\/10.5281\/zenodo.8319748. (Eficacia y seguridad de la atorvastatina en eventos cardiovasculares mayores: metaan\u00e1lisis)","journal-title":"Rev Med Inst Mex Seguro Soc."},{"issue":"3","key":"4559_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1185\/030079903125001668","volume":"19","author":"AS Wierzbicki","year":"2003","unstructured":"Wierzbicki AS, Mikhailidis DP, Wray R et al (2003) Statin-fibrate combination therapy for hyperlipidaemia: a review. Curr Med Res Opin 19(3):155\u2013168. https:\/\/doi.org\/10.1185\/030079903125001668","journal-title":"Curr Med Res Opin"},{"key":"4559_CR23","doi-asserted-by":"publisher","unstructured":"Yan L, Huang D, Shen J, Yang M, Wang S. Statin\u2011associated myasthenia gravis: a real-world retrospective and pharmacovigilance study. Expert Opin Drug Saf. 2025;1\u20138. https:\/\/doi.org\/10.1080\/14740338.2025.2467183","DOI":"10.1080\/14740338.2025.2467183"},{"issue":"1","key":"4559_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40360-024-00813-y","volume":"25","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Yao L (2024) Drug risks associated with sarcopenia: a real-world and GWAS study. BMC Pharmacol Toxicol 25(1):84. https:\/\/doi.org\/10.1186\/s40360-024-00813-y","journal-title":"BMC Pharmacol Toxicol"},{"key":"4559_CR25","doi-asserted-by":"publisher","first-page":"806081","DOI":"10.3389\/fcell.2022.806081","volume":"10","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Qu H, Chen Y et al (2022) Atorvastatin induces mitochondria-dependent ferroptosis via the modulation of Nrf2-xCT\/GPx4 axis. Front Cell Dev Biol 10:806081. https:\/\/doi.org\/10.3389\/fcell.2022.806081","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"4559_CR26","doi-asserted-by":"publisher","first-page":"e41460","DOI":"10.1097\/md.0000000000041460","volume":"104","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhao P, Huang H (2025) Adverse events of capmatinib: a real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database. Med (Baltimore). 104(5):e41460. https:\/\/doi.org\/10.1097\/md.0000000000041460","journal-title":"Med (Baltimore)."},{"key":"4559_CR27","doi-asserted-by":"publisher","first-page":"1526959","DOI":"10.3389\/fneur.2025.1526959","volume":"16","author":"H Zhang","year":"2025","unstructured":"Zhang H, Huang H, Zhao P (2025) Correlation of atorvastatin with subjective memory deficits: a study from the NHANES and FAERS databases. Front Neurol 16:1526959. https:\/\/doi.org\/10.3389\/fneur.2025.1526959","journal-title":"Front Neurol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04559-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04559-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04559-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T08:00:26Z","timestamp":1772006426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04559-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4559"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04559-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6960351\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocols of NHANES were approved by the institutional review board of the National Center for Health Statistics, CDC (\n                      \n                      ). All participants provided written consent after being fully informed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}